METHYLDOPA

METHYLDOPA was reported 4935 times

METHYLDOPA is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PERSISTENT CLOACA 18 0.4737
1 DIABETIC FOETOPATHY 27 0.4154
2 SALIVARY GLAND CANCER STAGE IV 6 0.4000
3 CONJOINED TWINS 36 0.3636
4 URACHAL ABNORMALITY 16 0.3556
5 BACTERIURIA IN PREGNANCY 3 0.3333
6 KINEMATIC IMBALANCES DUE TO SUBOCCIPITAL STRAIN 7 0.3043
7 CONUS MEDULLARIS SYNDROME 19 0.2923
8 ADIPOSIS DOLOROSA 11 0.2292
9 ULTRASOUND UTERUS ABNORMAL 11 0.2075
10 CONGENITAL AQUEDUCTAL STENOSIS 4 0.2000
11 BLOOD ANTIDIURETIC HORMONE DECREASED 4 0.1333
12 CONGENITAL BLADDER ANOMALY 18 0.1333
13 NEUTROPENIA NEONATAL 28 0.1250
14 DECREASED VENTRICULAR PRELOAD 3 0.1250
15 CONGENITAL SPINAL CORD ANOMALY 10 0.1190
16 DELAYED FONTANELLE CLOSURE 11 0.1146
17 FUNGAL MYOSITIS 4 0.1143
18 SUPERNUMERARY NIPPLE 9 0.1098
19 TERATOGENICITY 31 0.1026
20 NEONATAL HYPOCALCAEMIA 7 0.0933
21 EXTERNAL AUDITORY CANAL ATRESIA 15 0.0926
22 CONGENITAL CYSTIC LUNG 11 0.0917
23 CONGENITAL INGUINAL HERNIA 19 0.0909
24 CONGENITAL PNEUMONIA 8 0.0842
25 URINE OXALATE INCREASED 6 0.0822
26 CONGENITAL VESICOURETERIC REFLUX 7 0.0814
27 CONGENITAL RENAL CYST 6 0.0789
28 BEZOLD-JARISCH REFLEX 3 0.0789
29 INTESTINAL MALROTATION 20 0.0758
30 HELLP SYNDROME 46 0.0750
31 EYELID PTOSIS CONGENITAL 7 0.0737
32 5-HYDROXYINDOLACETIC ACID IN URINE INCREASED 4 0.0727
33 NEONATAL SEIZURE 18 0.0723
34 CONGENITAL CHOROID PLEXUS CYST 22 0.0721
35 NEONATAL RESPIRATORY FAILURE 36 0.0711
36 FOETAL DISORDER 55 0.0658
37 CAMPTODACTYLY CONGENITAL 5 0.0658
38 KIDNEY DUPLEX 15 0.0625
39 CONGENITAL HEARING DISORDER 10 0.0617
40 OESOPHAGEAL ATRESIA 36 0.0576
41 CONGENITAL MUSCULOSKELETAL DISORDER OF LIMBS 6 0.0571
42 INFANTILE HAEMANGIOMA 9 0.0556
43 HYPOCALVARIA 6 0.0517
44 PLACENTAL INSUFFICIENCY 41 0.0511
45 LARGE FOR DATES BABY 45 0.0510
46 MATERNAL CONDITION AFFECTING FOETUS 11 0.0498
47 CEREBRAL HAEMORRHAGE FOETAL 3 0.0492
48 LOW BIRTH WEIGHT BABY 389 0.0489
49 UMBILICAL CORD VASCULAR DISORDER 7 0.0486
50 PERIPARTUM CARDIOMYOPATHY 8 0.0465
51 CORTISOL FREE URINE INCREASED 3 0.0448
52 PRE-ECLAMPSIA 208 0.0437
53 CRANIAL SUTURES WIDENING 6 0.0435
54 ANGIOTENSIN CONVERTING ENZYME INHIBITOR FOETOPATHY 4 0.0426
55 CONGENITAL HYDRONEPHROSIS 30 0.0420
56 MICROTIA 13 0.0413
57 PULMONARY VALVE STENOSIS CONGENITAL 18 0.0411
58 FALLOPIAN TUBE DISORDER 12 0.0407
59 POLYSEROSITIS 17 0.0399
60 UTERINE HYPOTONUS 5 0.0397
61 GLIOSIS 17 0.0396
62 NEWBORN PERSISTENT PULMONARY HYPERTENSION 11 0.0391
63 HYPOSPADIAS 80 0.0384
64 FOETAL GROWTH RETARDATION 29 0.0370
65 PATENT DUCTUS ARTERIOSUS 147 0.0370
66 PREMATURE DELIVERY 584 0.0366
67 FEEDING DISORDER OF INFANCY OR EARLY CHILDHOOD 6 0.0366
68 RENAL FAILURE NEONATAL 8 0.0360
69 FOETAL MONITORING ABNORMAL 6 0.0359
70 FOETAL GROWTH RESTRICTION 216 0.0355
71 ADNEXAL TORSION 11 0.0347
72 THYMUS HYPOPLASIA 6 0.0345
73 SELECTIVE EATING DISORDER 31 0.0341
74 CONGENITAL RENAL DISORDER 9 0.0338
75 FOETAL EXPOSURE TIMING UNSPECIFIED 24 0.0334
76 ACCESSORY SPLEEN 3 0.0333
77 SMALL FOR DATES BABY 164 0.0330
78 NEONATAL HYPONATRAEMIA 4 0.0328
79 PROCTECTOMY 9 0.0327
80 URETERIC STENOSIS 26 0.0325
81 COLOBOMA 6 0.0321
82 MENINGOCELE 5 0.0318
83 OVARIAN FAILURE 17 0.0318
84 FOETAL CARDIAC DISORDER 10 0.0316
85 PREGNANCY INDUCED HYPERTENSION 5 0.0311
86 PREMATURE BABY 930 0.0309
87 OLIGOHYDRAMNIOS 103 0.0309
88 INSULIN AUTOIMMUNE SYNDROME 11 0.0308
89 POLYHYDRAMNIOS 31 0.0304
90 NEONATAL PNEUMONIA 7 0.0298
91 CEREBELLAR HYPOPLASIA 5 0.0298
92 BRACHYCEPHALY 3 0.0297
93 MICROPHTHALMOS 8 0.0294
94 OBSTRUCTED LABOUR 5 0.0294
95 DISABILITY ASSESSMENT SCALE SCORE INCREASED 9 0.0293
96 HIGH ARCHED PALATE 5 0.0292
97 HYPOGLYCAEMIA NEONATAL 47 0.0290
98 RENAL HYPERTENSION 9 0.0289
99 ULTRASOUND DOPPLER ABNORMAL 5 0.0289
100 CARDIAC SEPTAL HYPERTROPHY 8 0.0289
101 CEREBRAL HAEMORRHAGE NEONATAL 6 0.0283
102 MICROCEPHALY 36 0.0281
103 HYPOTHERMIA NEONATAL 4 0.0280
104 PULMONARY HYPOPLASIA 22 0.0279
105 ATELECTASIS NEONATAL 3 0.0278
106 RESPIRATORY DISORDER NEONATAL 45 0.0277
107 HYDROPS FOETALIS 17 0.0277
108 FOETAL HEART RATE DECELERATION ABNORMALITY 19 0.0269
109 HYPERTONIA NEONATAL 14 0.0262
110 PLAGIOCEPHALY 13 0.0261
111 CONGENITAL ARTERIAL MALFORMATION 5 0.0260
112 CONGENITAL CENTRAL NERVOUS SYSTEM ANOMALY 28 0.0259
113 WEIGHT DECREASE NEONATAL 5 0.0258
114 INFANTILE APNOEA 21 0.0257
115 AMNIOTIC FLUID VOLUME INCREASED 4 0.0253
116 AGITATION NEONATAL 24 0.0250
117 APGAR SCORE LOW 32 0.0248
118 GESTATIONAL HYPERTENSION 31 0.0240
119 ATRIAL SEPTAL DEFECT 196 0.0234
120 RENAL HYPOPLASIA 5 0.0229
121 BLOOD ALDOSTERONE INCREASED 4 0.0229
122 ANOMALY OF EXTERNAL EAR CONGENITAL 7 0.0222
123 AMNIOTIC FLUID VOLUME DECREASED 12 0.0219
124 CLINODACTYLY 6 0.0218
125 DIAPHRAGMATIC PARALYSIS 13 0.0217
126 FOETAL MACROSOMIA 6 0.0216
127 NEONATAL RESPIRATORY DISTRESS SYNDROME 76 0.0215
128 RICKETS 4 0.0212
129 ILEOSTOMY CLOSURE 7 0.0209
130 FAILED INDUCTION OF LABOUR 4 0.0206
131 HYPOTONIA NEONATAL 31 0.0198
132 RETINOPATHY HYPERTENSIVE 6 0.0198
133 NEONATAL ASPHYXIA 14 0.0197
134 POUCHITIS 17 0.0197
135 PHAEOCHROMOCYTOMA 13 0.0197
136 CONGENITAL HYDROCEPHALUS 10 0.0197
137 LIVE BIRTH 165 0.0197
138 CRYPTORCHISM 22 0.0196
139 JOINT ANKYLOSIS 11 0.0194
140 KERATITIS FUNGAL 4 0.0192
141 PLACENTAL DISORDER 18 0.0190
142 ADACTYLY 3 0.0186
143 PREMATURE MENOPAUSE 17 0.0184
144 TETHERED CORD SYNDROME 4 0.0181
145 RENAL DYSPLASIA 7 0.0181
146 PERSISTENT FOETAL CIRCULATION 11 0.0180
147 ANDROGENETIC ALOPECIA 5 0.0176
148 BRADYCARDIA NEONATAL 22 0.0175
149 FOETAL DISTRESS SYNDROME 37 0.0174
150 GESTATIONAL DIABETES 83 0.0174
151 FOETAL HEART RATE DECELERATION 4 0.0172
152 FEEDING DISORDER NEONATAL 18 0.0172
153 PULMONARY MALFORMATION 6 0.0171
154 CONGENITAL HEART VALVE DISORDER 4 0.0168
155 JOINT CONTRACTURE 18 0.0168
156 FOETAL EXPOSURE DURING PREGNANCY 1364 0.0168
157 HYPERTELORISM OF ORBIT 7 0.0167
158 DUCTUS ARTERIOSUS STENOSIS FOETAL 7 0.0164
159 ECLAMPSIA 6 0.0163
160 NEONATAL HYPOTENSION 6 0.0163
161 PULMONARY VALVE STENOSIS 13 0.0163
162 THREATENED LABOUR 7 0.0163
163 PREMATURE SEPARATION OF PLACENTA 25 0.0162
164 SEPSIS NEONATAL 13 0.0160
165 SOMATIC SYMPTOM DISORDER 17 0.0157
166 NEONATAL HYPOXIA 13 0.0157
167 CONGENITAL NOSE MALFORMATION 8 0.0150
168 CEPHALO-PELVIC DISPROPORTION 3 0.0150
169 PREMATURE LABOUR 84 0.0148
170 VENTRICULAR SEPTAL DEFECT 84 0.0147
171 SMALL CELL CARCINOMA 5 0.0145
172 NEONATAL INFECTION 5 0.0145
173 BRADYCARDIA FOETAL 12 0.0144
174 CAESAREAN SECTION 168 0.0144
175 FOETAL HYPOKINESIA 10 0.0143
176 MICROSPORIDIA INFECTION 5 0.0142
177 MICROGNATHIA 7 0.0140
178 NORMAL NEWBORN 76 0.0140
179 HYPEREMESIS GRAVIDARUM 5 0.0130
180 PULMONARY ARTERY STENOSIS 5 0.0128
181 LIMB MALFORMATION 10 0.0127
182 ARRESTED LABOUR 3 0.0127
183 RETINOPATHY OF PREMATURITY 7 0.0126
184 HAEMANGIOMA CONGENITAL 6 0.0126
185 PYELOCALIECTASIS 12 0.0125
186 PREMATURE RUPTURE OF MEMBRANES 30 0.0124
187 BRONCHOPULMONARY DYSPLASIA 10 0.0124
188 BLOOD PRESSURE DIASTOLIC ABNORMAL 31 0.0122
189 MATERNAL EXPOSURE DURING DELIVERY 12 0.0121
190 NEONATAL TACHYPNOEA 5 0.0121
191 TOXOPLASMOSIS 13 0.0120
192 BREECH PRESENTATION 15 0.0119
193 THROMBOCYTOPENIA NEONATAL 5 0.0119
194 CERVICAL INCOMPETENCE 6 0.0118
195 ADRENAL ADENOMA 7 0.0117
196 PRETERM PREMATURE RUPTURE OF MEMBRANES 14 0.0116
197 APNOEA NEONATAL 3 0.0116
198 RENAL APLASIA 8 0.0114
199 MECONIUM IN AMNIOTIC FLUID 4 0.0114
200 KIDNEY MALFORMATION 4 0.0114
201 HAEMOPERITONEUM 9 0.0112
202 EXPOSURE DURING PREGNANCY 698 0.0112
203 GLOMERULOSCLEROSIS 7 0.0111
204 SKULL MALFORMATION 7 0.0109
205 INTESTINAL ANASTOMOSIS 7 0.0109
206 CONGENITAL UMBILICAL HERNIA 4 0.0107
207 ANTIPHOSPHOLIPID SYNDROME 17 0.0106
208 MACROCEPHALY 4 0.0103
209 BICUSPID AORTIC VALVE 6 0.0101
210 EXPOSURE VIA BREAST MILK 40 0.0100
211 INTRA-UTERINE DEATH 16 0.0100
212 NECROTISING ENTEROCOLITIS NEONATAL 4 0.0099
213 LOW SET EARS 4 0.0097
214 DEVELOPMENTAL HIP DYSPLASIA 8 0.0096
215 CORTISOL INCREASED 6 0.0096
216 MATERNAL EXPOSURE TIMING UNSPECIFIED 36 0.0096
217 JAUNDICE NEONATAL 18 0.0095
218 UMBILICAL CORD ABNORMALITY 5 0.0095
219 NEONATAL DISORDER 15 0.0095
220 RENAL ARTERY STENOSIS 13 0.0094
221 MATERNAL EXPOSURE DURING PREGNANCY 838 0.0094
222 CYANOSIS NEONATAL 6 0.0094
223 KIDNEY ENLARGEMENT 10 0.0092
224 CLEFT LIP AND PALATE 10 0.0089
225 TRANSPOSITION OF THE GREAT VESSELS 7 0.0089
226 CONTRAINDICATED PRODUCT PRESCRIBED 15 0.0089
227 FOETAL DEATH 46 0.0089
228 BLOOD CHROMOGRANIN A INCREASED 4 0.0087
229 HEMIANOPIA HOMONYMOUS 6 0.0082
230 INFERTILITY 12 0.0080
231 COMPLICATION OF PREGNANCY 6 0.0079
232 VENOUS THROMBOSIS LIMB 16 0.0077
233 BLOOD PRESSURE SYSTOLIC ABNORMAL 19 0.0077
234 CONGENITAL DIAPHRAGMATIC HERNIA 3 0.0077
235 NAIL INFECTION 11 0.0077
236 MATERNAL DRUGS AFFECTING FOETUS 58 0.0076
237 SINGLE FUNCTIONAL KIDNEY 5 0.0076
238 MYOGLOBINURIA 4 0.0075
239 HAPTOGLOBIN DECREASED 6 0.0074
240 TEMPERATURE REGULATION DISORDER 16 0.0072
241 HAEMANGIOMA OF LIVER 7 0.0069
242 RIGHT VENTRICULAR DILATATION 4 0.0069
243 POLYDACTYLY 8 0.0069
244 HYPERBILIRUBINAEMIA NEONATAL 4 0.0069
245 DYSMORPHISM 16 0.0068
246 HYPERTENSIVE ENCEPHALOPATHY 4 0.0067
247 AORTIC VALVE STENOSIS 12 0.0067
248 POSTPARTUM HAEMORRHAGE 9 0.0067
249 DEATH NEONATAL 9 0.0065
250 LOWER RESPIRATORY TRACT CONGESTION 11 0.0065
251 DIAPHRAGMATIC HERNIA 4 0.0065
252 FOETAL MALFORMATION 7 0.0064
253 BLOOD PRESSURE DIASTOLIC INCREASED 29 0.0063
254 ANAEMIA NEONATAL 3 0.0062
255 BLOOD CORTICOTROPHIN DECREASED 3 0.0061
256 JOINT NOISE 12 0.0061
257 FOETAL EXPOSURE DURING DELIVERY 4 0.0059
258 HYPOPLASTIC LEFT HEART SYNDROME 4 0.0059
259 STILLBIRTH 28 0.0058
260 ARTERIAL STENOSIS 5 0.0057
261 RENAL TUBULAR ATROPHY 5 0.0057
262 HYPERTENSIVE NEPHROPATHY 6 0.0056
263 MULTIPLE CONGENITAL ABNORMALITIES 8 0.0056
264 GLUCOSE URINE PRESENT 7 0.0055
265 DRUG EXPOSURE VIA BREAST MILK 6 0.0055
266 PULMONARY ARTERY STENOSIS CONGENITAL 4 0.0055
267 MATERNAL EXPOSURE DURING BREAST FEEDING 22 0.0054
268 ISCHAEMIC CEREBRAL INFARCTION 6 0.0052
269 TALIPES 16 0.0051
270 DYSPLASIA 6 0.0050
271 ATYPICAL HAEMOLYTIC URAEMIC SYNDROME 4 0.0049
272 HYPOPERFUSION 5 0.0048
273 UTERINE DISORDER 11 0.0047
274 CLEFT PALATE 9 0.0047
275 BLOOD PRESSURE INADEQUATELY CONTROLLED 28 0.0046
276 CARDIAC TAMPONADE 22 0.0046
277 DELIVERY 3 0.0046
278 BONE DEFORMITY 3 0.0045
279 INGUINAL HERNIA 27 0.0044
280 VENTRICULAR HYPERTROPHY 11 0.0044
281 FOCAL SEGMENTAL GLOMERULOSCLEROSIS 7 0.0044
282 CEREBRAL CYST 3 0.0044
283 DRUG EXPOSURE DURING PREGNANCY 148 0.0043
284 OLIGURIA 27 0.0043
285 RETINOPATHY 16 0.0043
286 UMBILICAL HERNIA 20 0.0043
287 HEPATITIS TOXIC 11 0.0042
288 LEFT VENTRICULAR HYPERTROPHY 18 0.0042
289 OVARIAN CYST 42 0.0042
290 ARNOLD-CHIARI MALFORMATION 4 0.0042
291 AZOTAEMIA 16 0.0040
292 RHEUMATOID NODULE 11 0.0040
293 ESSENTIAL HYPERTENSION 7 0.0038
294 FINE MOTOR SKILL DYSFUNCTION 11 0.0038
295 ELECTROMECHANICAL DISSOCIATION 3 0.0038
296 SUBDURAL HAEMORRHAGE 10 0.0037
297 BRADYARRHYTHMIA 6 0.0036
298 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 8 0.0036
299 RESUSCITATION 6 0.0036
300 INTRAVENTRICULAR HAEMORRHAGE 9 0.0036
301 HAEMOGLOBINURIA 4 0.0036
302 CONGENITAL CYSTIC KIDNEY DISEASE 3 0.0035
303 ILEOSTOMY 9 0.0035
304 CEREBRAL VENTRICLE DILATATION 4 0.0035
305 KIDNEY FIBROSIS 6 0.0035
306 GROWTH RETARDATION 10 0.0034
307 BLOOD CREATINE INCREASED 15 0.0034
308 IMMUNOSUPPRESSANT DRUG LEVEL DECREASED 4 0.0033
309 DILATATION VENTRICULAR 7 0.0033
310 RENAL TUBULAR INJURY 4 0.0033
311 MATERNAL EXPOSURE BEFORE PREGNANCY 22 0.0032
312 LUPUS NEPHRITIS 6 0.0032
313 RENAL ATROPHY 4 0.0032
314 FOOT DEFORMITY 35 0.0032
315 LIMB DEFORMITY 5 0.0031
316 GASTRIC INFECTION 12 0.0031
317 OPTIC ATROPHY 5 0.0031
318 PYELONEPHRITIS ACUTE 6 0.0031
319 PROTEINURIA 53 0.0028
320 ARRHYTHMIA SUPRAVENTRICULAR 3 0.0027
321 ABORTION 8 0.0027
322 ONYCHOMYCOSIS 12 0.0027
323 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 26 0.0027
324 HYPERTENSIVE CRISIS 29 0.0026
325 ABORTION INDUCED 24 0.0025
326 ANORECTAL DISORDER 5 0.0025
327 DRUG-INDUCED LIVER INJURY 75 0.0024
328 PREGNANCY 47 0.0023
329 DIABETIC NEPHROPATHY 5 0.0023
330 DIASTOLIC DYSFUNCTION 7 0.0023
331 HEART DISEASE CONGENITAL 8 0.0023
332 TRANSPLANT DYSFUNCTION 4 0.0022
333 PROTEIN URINE PRESENT 11 0.0022
334 MULTIPLE DRUG OVERDOSE INTENTIONAL 7 0.0022
335 NEPHROGENIC ANAEMIA 10 0.0022
336 WEIGHT LOSS POOR 11 0.0021
337 BLOOD ALBUMIN DECREASED 17 0.0021
338 CULTURE URINE POSITIVE 3 0.0021
339 LUPUS-LIKE SYNDROME 19 0.0021
340 HYPOREFLEXIA 4 0.0021
341 CEREBRAL HAEMATOMA 7 0.0021
342 ESCHERICHIA SEPSIS 6 0.0021
343 APNOEA 16 0.0021
344 NEPHROTIC SYNDROME 14 0.0020
345 CARDIOMEGALY 25 0.0020
346 HYDROCEPHALUS 11 0.0020
347 TRICUSPID VALVE INCOMPETENCE 16 0.0020
348 AORTIC STENOSIS 7 0.0020
349 MUSCLE CONTRACTURE 4 0.0020
350 CONTRAINDICATION TO MEDICAL TREATMENT 3 0.0020
351 DEFORMITY 18 0.0019
352 SPINA BIFIDA 4 0.0019
353 ATRIAL TACHYCARDIA 4 0.0019
354 BLOOD PRESSURE SYSTOLIC INCREASED 37 0.0019
355 BLADDER PAIN 6 0.0019
356 HAEMOGLOBIN ABNORMAL 12 0.0019
357 HYPERPHOSPHATAEMIA 4 0.0019
358 HEPATIC NECROSIS 7 0.0019
359 MYASTHENIA GRAVIS 15 0.0019
360 RIGHT VENTRICULAR FAILURE 13 0.0019
361 ATRIOVENTRICULAR BLOCK FIRST DEGREE 8 0.0018
362 HYPERVOLAEMIA 9 0.0018
363 EXPOSURE DURING BREAST FEEDING 6 0.0018
364 HAEMODIALYSIS 15 0.0018
365 ENDOTRACHEAL INTUBATION 5 0.0018
366 CEREBRAL ATROPHY 7 0.0018
367 DENGUE FEVER 4 0.0017
368 HAEMANGIOMA 4 0.0017
369 ENTERITIS 11 0.0017
370 POLYURIA 14 0.0017
371 HYPERURICAEMIA 7 0.0017
372 ACIDOSIS 13 0.0017
373 THERMAL BURN 12 0.0017
374 CONGENITAL ANOMALY 13 0.0017
375 ABORTION SPONTANEOUS 67 0.0017
376 CONTRAINDICATED PRODUCT ADMINISTERED 50 0.0016
377 CUTANEOUS VASCULITIS 6 0.0016
378 ANURIA 14 0.0016
379 ONYCHOCLASIS 11 0.0016
380 PARKINSON'S DISEASE 4 0.0016
381 ARTERIAL DISORDER 3 0.0016
382 ORTHOPNOEA 5 0.0016
383 HEPATOCELLULAR INJURY 22 0.0016
384 DEAFNESS NEUROSENSORY 5 0.0015
385 LARYNGOSPASM 4 0.0015
386 DRUG WITHDRAWAL SYNDROME NEONATAL 22 0.0015
387 ENURESIS 6 0.0015
388 TACHYPNOEA 20 0.0015
389 THYROID NEOPLASM 4 0.0014
390 BLOOD CREATININE ABNORMAL 5 0.0014
391 ESCHERICHIA URINARY TRACT INFECTION 6 0.0014
392 HYPERNATRAEMIA 7 0.0014
393 HYPERBILIRUBINAEMIA 14 0.0014
394 MITRAL VALVE INCOMPETENCE 15 0.0013
395 ATRIOVENTRICULAR BLOCK SECOND DEGREE 4 0.0013
396 HAEMOLYSIS 10 0.0013
397 NEPHROPATHY 12 0.0013
398 PROSTATOMEGALY 5 0.0013
399 VULVOVAGINAL MYCOTIC INFECTION 5 0.0013
400 KIDNEY TRANSPLANT REJECTION 6 0.0012
401 CUSHINGOID 4 0.0012
402 COLECTOMY 7 0.0012
403 BLOOD IMMUNOGLOBULIN E INCREASED 3 0.0012
404 BREATH ODOUR 3 0.0012
405 HYPERTENSION 259 0.0012
406 HYPOPHOSPHATAEMIA 9 0.0012
407 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 31 0.0012
408 AORTIC VALVE INCOMPETENCE 5 0.0012
409 UTERINE HAEMORRHAGE 5 0.0012
410 NERVE INJURY 13 0.0012
411 AUTOIMMUNE HAEMOLYTIC ANAEMIA 4 0.0012
412 BLOOD PRESSURE FLUCTUATION 28 0.0012
413 BURSITIS 14 0.0012
414 DIVERTICULUM INTESTINAL 5 0.0011
415 RENAL CYST 9 0.0011
416 CYST 14 0.0011
417 AREFLEXIA 3 0.0011
418 ASCITES 32 0.0011
419 DRUG SCREEN FALSE POSITIVE 3 0.0011
420 HYPOMAGNESAEMIA 15 0.0011
421 HYDRONEPHROSIS 8 0.0011
422 COLITIS MICROSCOPIC 5 0.0011
423 HAEMODYNAMIC INSTABILITY 8 0.0010
424 HYPERTONIA 6 0.0010
425 RENAL FAILURE CHRONIC 8 0.0010
426 CARDIAC MURMUR 9 0.0010
427 BLOOD URIC ACID INCREASED 6 0.0010
428 PHOTOSENSITIVITY REACTION 17 0.0010
429 DIABETES MELLITUS INADEQUATE CONTROL 18 0.0010
430 PERITONITIS 21 0.0010
431 STAPHYLOCOCCAL SEPSIS 5 0.0010
432 POLYDIPSIA 4 0.0010
433 DIABETIC NEUROPATHY 5 0.0010
434 CREPITATIONS 3 0.0010
435 OESOPHAGEAL CANDIDIASIS 4 0.0010
436 NODULE 13 0.0010
437 BLOOD CREATININE INCREASED 65 0.0010
438 TOXIC ENCEPHALOPATHY 5 0.0010
439 LARYNGEAL OEDEMA 6 0.0010
440 HYPERCALCAEMIA 12 0.0010
441 EUGLYCAEMIC DIABETIC KETOACIDOSIS 4 0.0010
442 HEART RATE DECREASED 34 0.0010
443 VARICOSE VEIN 5 0.0010
444 HAEMATOCRIT DECREASED 19 0.0010
445 PULSELESS ELECTRICAL ACTIVITY 4 0.0010
446 HYPOGLYCAEMIA 46 0.0009
447 BILE DUCT STONE 3 0.0009
448 END STAGE RENAL DISEASE 17 0.0009
449 BLOOD IRON DECREASED 11 0.0009
450 THROMBOTIC MICROANGIOPATHY 9 0.0009
451 ANTINUCLEAR ANTIBODY POSITIVE 3 0.0009
452 MYOCLONUS 11 0.0009
453 RENAL TUBULAR NECROSIS 9 0.0009
454 SINUS TACHYCARDIA 13 0.0009
455 INTERVERTEBRAL DISC PROTRUSION 20 0.0009
456 BODY TEMPERATURE DECREASED 9 0.0009
457 AUTISM SPECTRUM DISORDER 5 0.0009
458 CARDIAC FAILURE ACUTE 6 0.0009
459 EYE HAEMORRHAGE 12 0.0009
460 NECROSIS 5 0.0009
461 INTRACRANIAL PRESSURE INCREASED 5 0.0009
462 CHOLECYSTITIS CHRONIC 6 0.0009
463 BLOOD UREA INCREASED 15 0.0009
464 JOINT RANGE OF MOTION DECREASED 12 0.0009
465 MYOCARDIAL ISCHAEMIA 10 0.0009
466 DIABETIC KETOACIDOSIS 21 0.0009
467 DRUG LEVEL ABOVE THERAPEUTIC 4 0.0009
468 OBSESSIVE-COMPULSIVE DISORDER 7 0.0009
469 BLOOD THYROID STIMULATING HORMONE INCREASED 8 0.0009
470 COORDINATION ABNORMAL 12 0.0009
471 RESPIRATORY FAILURE 62 0.0008
472 RENAL FAILURE ACUTE 36 0.0008
473 CARDIOGENIC SHOCK 12 0.0008
474 SINUS BRADYCARDIA 8 0.0008
475 BLOOD PRESSURE INCREASED 125 0.0008
476 BLOOD PRESSURE DIASTOLIC DECREASED 6 0.0008
477 ACUTE HEPATIC FAILURE 11 0.0008
478 HYPOKALAEMIA 37 0.0008
479 AMENORRHOEA 14 0.0008
480 LUNG INFILTRATION 7 0.0008
481 DYSLIPIDAEMIA 4 0.0008
482 COMMUNICATION DISORDER 3 0.0008
483 ENDOCARDITIS 4 0.0008
484 CEREBRAL ISCHAEMIA 4 0.0008
485 PLEURAL EFFUSION 47 0.0008
486 HYPOALBUMINAEMIA 6 0.0008
487 HEPATITIS ACUTE 5 0.0008
488 HAEMORRHAGIC STROKE 6 0.0008
489 PULMONARY HYPERTENSION 16 0.0008
490 HEPATOTOXICITY 17 0.0008
491 BLOOD LACTATE DEHYDROGENASE INCREASED 12 0.0008
492 APATHY 11 0.0008
493 HYPOTHYROIDISM 24 0.0008
494 SENSORY DISTURBANCE 12 0.0007
495 LEFT VENTRICULAR DYSFUNCTION 5 0.0007
496 HYPOCALCAEMIA 14 0.0007
497 HAEMORRHAGE INTRACRANIAL 11 0.0007
498 SYSTEMIC LUPUS ERYTHEMATOSUS 26 0.0007
499 INFARCTION 5 0.0007
500 ANAPHYLACTOID REACTION 3 0.0007
501 EXTRASYSTOLES 5 0.0007
502 ANGIOPATHY 4 0.0007
503 ACUTE PULMONARY OEDEMA 4 0.0007
504 CHOLECYSTITIS ACUTE 4 0.0007
505 CARDIAC FAILURE CHRONIC 3 0.0007
506 RENAL IMPAIRMENT 59 0.0007
507 HYPOTONIA 7 0.0007
508 RENAL FAILURE 93 0.0007
509 OXYGEN SATURATION DECREASED 39 0.0007
510 NEUTROPHIL COUNT INCREASED 7 0.0007
511 HYPERTRIGLYCERIDAEMIA 4 0.0007
512 ODYNOPHAGIA 4 0.0007
513 HAEMOLYTIC ANAEMIA 6 0.0007
514 JAUNDICE 18 0.0007
515 PROTHROMBIN TIME PROLONGED 4 0.0007
516 FREQUENT BOWEL MOVEMENTS 18 0.0007
517 OEDEMA PERIPHERAL 81 0.0007
518 GENERALISED OEDEMA 8 0.0006
519 VAGINAL HAEMORRHAGE 28 0.0006
520 BLOOD GLUCOSE FLUCTUATION 7 0.0006
521 METASTASES TO LIVER 11 0.0006
522 BRADYCARDIA 33 0.0006
523 PRESYNCOPE 15 0.0006
524 RESPIRATORY DISTRESS 17 0.0006
525 ANGINA UNSTABLE 4 0.0006
526 REFUSAL OF TREATMENT BY PATIENT 4 0.0006
527 CARDIOMYOPATHY 9 0.0006
528 PERICARDIAL EFFUSION 14 0.0006
529 BLOOD PRESSURE ABNORMAL 12 0.0006
530 COAGULOPATHY 10 0.0006
531 ATRIOVENTRICULAR BLOCK COMPLETE 4 0.0006
532 SPINAL PAIN 7 0.0006
533 CYSTITIS 19 0.0006
534 ECONOMIC PROBLEM 9 0.0006
535 BLOOD BILIRUBIN INCREASED 16 0.0006
536 POSTOPERATIVE WOUND INFECTION 4 0.0006
537 NECK PAIN 33 0.0006
538 CACHEXIA 3 0.0006
539 MULTI-ORGAN FAILURE 10 0.0006
540 DIPLOPIA 15 0.0006
541 URINE OUTPUT DECREASED 5 0.0006
542 HYPERKALAEMIA 20 0.0006
543 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 5 0.0006
544 ORAL HERPES 11 0.0006
545 RESPIRATORY RATE INCREASED 5 0.0006
546 DEVELOPMENTAL DELAY 5 0.0006
547 ABDOMINAL PAIN LOWER 14 0.0006
548 FAECES SOFT 4 0.0005
549 RETINAL DETACHMENT 5 0.0005
550 IRON DEFICIENCY ANAEMIA 5 0.0005
551 SKIN ULCER 14 0.0005
552 TRANSAMINASES INCREASED 12 0.0005
553 CEREBRAL INFARCTION 13 0.0005
554 METABOLIC ACIDOSIS 17 0.0005
555 DYSARTHRIA 20 0.0005
556 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 9 0.0005
557 SPEECH DISORDER 27 0.0005
558 DYSSTASIA 15 0.0005
559 THERAPY NON-RESPONDER 23 0.0005
560 PULMONARY HAEMORRHAGE 4 0.0005
561 DRUG SCREEN POSITIVE 4 0.0005
562 CHOLECYSTITIS 6 0.0005
563 HEPATIC ENZYME INCREASED 34 0.0005
564 RHINITIS 4 0.0005
565 DIALYSIS 7 0.0005
566 BRONCHOSPASM 7 0.0005
567 LIVER INJURY 12 0.0005
568 ANGINA PECTORIS 14 0.0005
569 HYPOACUSIS 21 0.0005
570 CHRONIC KIDNEY DISEASE 37 0.0005
571 ESCHERICHIA INFECTION 4 0.0005
572 CONCOMITANT DISEASE AGGRAVATED 3 0.0005
573 PULMONARY ARTERIAL HYPERTENSION 7 0.0005
574 VENTRICULAR EXTRASYSTOLES 5 0.0005
575 PETECHIAE 5 0.0005
576 UTERINE PERFORATION 4 0.0005
577 RENAL DISORDER 22 0.0005
578 SLEEP APNOEA SYNDROME 9 0.0005
579 ASPARTATE AMINOTRANSFERASE INCREASED 25 0.0005
580 DIVERTICULITIS 13 0.0005
581 DRUG RESISTANCE 12 0.0005
582 ARRHYTHMIA 22 0.0005
583 CARDIAC FLUTTER 3 0.0005
584 ORTHOSTATIC HYPOTENSION 8 0.0005
585 OESOPHAGITIS 5 0.0005
586 JOINT STIFFNESS 12 0.0005
587 HEPATIC FUNCTION ABNORMAL 17 0.0005
588 PULMONARY CONGESTION 6 0.0005
589 HERPES ZOSTER 26 0.0005
590 BLOOD CREATINE PHOSPHOKINASE INCREASED 13 0.0005
591 VENTRICULAR FIBRILLATION 5 0.0004
592 COGNITIVE DISORDER 21 0.0004
593 CARDIOTOXICITY 4 0.0004
594 FACIAL PAIN 4 0.0004
595 PANCREATITIS ACUTE 10 0.0004
596 BLOOD ALKALINE PHOSPHATASE INCREASED 11 0.0004
597 LEUKOCYTOSIS 8 0.0004
598 ATRIAL FIBRILLATION 43 0.0004
599 EXOSTOSIS 4 0.0004
600 FLUID RETENTION 22 0.0004
601 RHEUMATOID ARTHRITIS 49 0.0004
602 AUTOIMMUNE HEPATITIS 3 0.0004
603 BLOOD POTASSIUM INCREASED 7 0.0004
604 SOMNOLENCE 86 0.0004
605 SQUAMOUS CELL CARCINOMA 4 0.0004
606 ANAEMIA 81 0.0004
607 THERAPEUTIC PRODUCT EFFECT DECREASED 19 0.0004
608 MULTIPLE ORGAN DYSFUNCTION SYNDROME 12 0.0004
609 DIVERTICULUM 3 0.0004
610 BACTERAEMIA 5 0.0004
611 DRUG PRESCRIBING ERROR 8 0.0004
612 PANIC ATTACK 15 0.0004
613 CIRCULATORY COLLAPSE 7 0.0004
614 NASAL CONGESTION 24 0.0004
615 ALANINE AMINOTRANSFERASE INCREASED 25 0.0004
616 HEPATOMEGALY 4 0.0004
617 GLOMERULAR FILTRATION RATE DECREASED 5 0.0004
618 DRUG INTERACTION 64 0.0004
619 COLITIS ULCERATIVE 18 0.0004
620 BRAIN INJURY 4 0.0004
621 GLYCOSYLATED HAEMOGLOBIN INCREASED 10 0.0004
622 SUICIDE ATTEMPT 24 0.0004
623 HEAD DISCOMFORT 7 0.0004
624 HYPOTHERMIA 4 0.0004
625 DEHYDRATION 52 0.0004
626 HYPOTENSION 78 0.0004
627 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 3 0.0004
628 TREATMENT NONCOMPLIANCE 21 0.0004
629 TACHYCARDIA 34 0.0004
630 DEAFNESS 10 0.0004
631 CYANOSIS 6 0.0004
632 ACUTE KIDNEY INJURY 58 0.0004
633 INCONTINENCE 4 0.0004
634 PNEUMOTHORAX 6 0.0004
635 EPISTAXIS 28 0.0004
636 CARDIAC FAILURE 30 0.0004
637 HEREDITARY ANGIOEDEMA 4 0.0004
638 ANXIETY 106 0.0004
639 DIABETES MELLITUS 28 0.0004
640 DRUG TOXICITY 5 0.0004
641 CHOLESTASIS 7 0.0004
642 CARDIAC ARREST 30 0.0004
643 DRUG LEVEL INCREASED 6 0.0004
644 EXTRAPYRAMIDAL DISORDER 9 0.0004
645 BLOOD PRESSURE DECREASED 24 0.0004
646 HYPOAESTHESIA 54 0.0004
647 RASH MACULO-PAPULAR 8 0.0004
648 HUNGER 5 0.0004
649 MALNUTRITION 4 0.0004
650 CARPAL TUNNEL SYNDROME 5 0.0004
651 COMA 17 0.0004
652 INTESTINAL PERFORATION 4 0.0004
653 ARTHRITIS 28 0.0004
654 FACE OEDEMA 6 0.0004
655 DISSEMINATED INTRAVASCULAR COAGULATION 5 0.0004
656 HYPONATRAEMIA 20 0.0004
657 TARDIVE DYSKINESIA 10 0.0004
658 HEMIPARESIS 6 0.0004
659 GASTRIC HAEMORRHAGE 4 0.0003
660 RESPIRATORY TRACT INFECTION 9 0.0003
661 INFECTION 50 0.0003
662 INJECTION SITE HAEMATOMA 5 0.0003
663 DYSPNOEA 195 0.0003
664 FLUID OVERLOAD 5 0.0003
665 HEART RATE INCREASED 34 0.0003
666 MYALGIA 58 0.0003
667 ACUTE RESPIRATORY DISTRESS SYNDROME 6 0.0003
668 DEPRESSION 77 0.0003
669 CELLULITIS 17 0.0003
670 ATAXIA 4 0.0003
671 CHOLELITHIASIS 11 0.0003
672 IMMUNODEFICIENCY 5 0.0003
673 PULMONARY OEDEMA 15 0.0003
674 MUSCLE RIGIDITY 4 0.0003
675 APHASIA 10 0.0003
676 MOOD ALTERED 9 0.0003
677 HYPERGLYCAEMIA 12 0.0003
678 GAIT INABILITY 11 0.0003
679 PLATELET COUNT DECREASED 35 0.0003
680 NO THERAPEUTIC RESPONSE 4 0.0003
681 RESPIRATORY DEPRESSION 4 0.0003
682 CHEST DISCOMFORT 33 0.0003
683 TUBULOINTERSTITIAL NEPHRITIS 6 0.0003
684 ARTERIOSCLEROSIS 3 0.0003
685 BLOOD SODIUM DECREASED 6 0.0003
686 DYSPHAGIA 30 0.0003
687 HEAD INJURY 10 0.0003
688 GASTRIC ULCER 6 0.0003
689 RASH ERYTHEMATOUS 15 0.0003
690 HEPATITIS 8 0.0003
691 MUSCULOSKELETAL PAIN 16 0.0003
692 SKIN DISCOLOURATION 14 0.0003
693 SHOCK 7 0.0003
694 BEDRIDDEN 4 0.0003
695 VENTRICULAR TACHYCARDIA 5 0.0003
696 GENERALISED TONIC-CLONIC SEIZURE 5 0.0003
697 HAEMOGLOBIN DECREASED 31 0.0003
698 PRESCRIBED UNDERDOSE 6 0.0003
699 INJURY 21 0.0003
700 OEDEMA 16 0.0003
701 SINUSITIS 30 0.0003
702 CORONARY ARTERY OCCLUSION 4 0.0003
703 PROSTATIC SPECIFIC ANTIGEN INCREASED 4 0.0003
704 URINARY TRACT INFECTION 49 0.0003
705 APHONIA 4 0.0003
706 BLINDNESS UNILATERAL 4 0.0003
707 BREAST PAIN 3 0.0003
708 LEUKOPENIA 14 0.0003
709 THIRST 5 0.0003
710 PARALYSIS 4 0.0003
711 WEIGHT DECREASED 78 0.0003
712 GOUT 5 0.0003
713 HALLUCINATION 21 0.0003
714 PRURITUS GENERALISED 6 0.0003
715 CEREBROVASCULAR ACCIDENT 47 0.0003
716 FAECES DISCOLOURED 6 0.0003
717 ERYTHEMA 56 0.0003
718 DYSURIA 10 0.0003
719 ANGIOEDEMA 12 0.0003
720 GAMMA-GLUTAMYLTRANSFERASE INCREASED 6 0.0003
721 BLOOD GLUCOSE ABNORMAL 5 0.0003
722 DYSKINESIA 11 0.0003
723 RENAL INJURY 8 0.0003
724 HEPATIC STEATOSIS 5 0.0003
725 GASTRITIS 7 0.0003
726 CORONARY ARTERY DISEASE 8 0.0003
727 OFF LABEL USE 231 0.0003
728 CARDIO-RESPIRATORY ARREST 11 0.0003
729 DRUG DISPENSING ERROR 4 0.0003
730 NEPHROLITHIASIS 12 0.0003
731 OSTEOARTHRITIS 11 0.0003
732 DRY MOUTH 21 0.0003
733 NEUTROPENIA 35 0.0003
734 PALLOR 7 0.0003
735 CONDITION AGGRAVATED 78 0.0003
736 NERVOUS SYSTEM DISORDER 8 0.0003
737 MUSCULAR WEAKNESS 29 0.0003
738 MENORRHAGIA 5 0.0003
739 ANAPHYLACTIC REACTION 14 0.0003
740 ACTIVITIES OF DAILY LIVING IMPAIRED 5 0.0003
741 PROCEDURAL PAIN 7 0.0003
742 CEREBRAL HAEMORRHAGE 9 0.0003
743 MUSCULOSKELETAL STIFFNESS 22 0.0003
744 OBESITY 4 0.0003
745 SCIATICA 4 0.0003
746 BLOOD GLUCOSE DECREASED 12 0.0002
747 MOVEMENT DISORDER 8 0.0002
748 NERVOUSNESS 13 0.0002
749 THERAPEUTIC RESPONSE DECREASED 15 0.0002
750 ABNORMAL WEIGHT GAIN 3 0.0002
751 PYREXIA 84 0.0002
752 VISUAL ACUITY REDUCED 8 0.0002
753 TYPE 2 DIABETES MELLITUS 8 0.0002
754 COLITIS 9 0.0002
755 CARDIOVASCULAR DISORDER 6 0.0002
756 THROMBOSIS 19 0.0002
757 SWELLING 22 0.0002
758 SCAR 4 0.0002
759 HEPATIC FAILURE 7 0.0002
760 HAEMATOMA 6 0.0002
761 MUSCLE SPASMS 42 0.0002
762 EMOTIONAL DISORDER 7 0.0002
763 CHEST PAIN 42 0.0002
764 GALLBLADDER DISORDER 4 0.0002
765 THROMBOCYTOPENIA 25 0.0002
766 FEAR 6 0.0002
767 PALPITATIONS 26 0.0002
768 GASTROENTERITIS VIRAL 4 0.0002
769 RESTLESS LEGS SYNDROME 4 0.0002
770 VISUAL IMPAIRMENT 27 0.0002
771 PAIN IN EXTREMITY 64 0.0002
772 VOMITING 102 0.0002
773 MENTAL STATUS CHANGES 6 0.0002
774 AGRANULOCYTOSIS 4 0.0002
775 NASOPHARYNGITIS 39 0.0002
776 ABDOMINAL DISTENSION 22 0.0002
777 SYNCOPE 21 0.0002
778 ARTHRALGIA 87 0.0002
779 GAIT DISTURBANCE 40 0.0002
780 LETHARGY 12 0.0002
781 CONTUSION 20 0.0002
782 ANOSMIA 3 0.0002
783 JOINT SWELLING 25 0.0002
784 SEPTIC SHOCK 9 0.0002
785 MENTAL DISORDER 9 0.0002
786 FIBROMYALGIA 5 0.0002
787 WEIGHT INCREASED 46 0.0002
788 HAEMATURIA 7 0.0002
789 KIDNEY INFECTION 4 0.0002
790 ENCEPHALOPATHY 5 0.0002
791 DRUG INEFFECTIVE 268 0.0002
792 LIVER DISORDER 9 0.0002
793 RESPIRATORY DISORDER 6 0.0002
794 SWELLING FACE 13 0.0002
795 INSOMNIA 53 0.0002
796 SLEEP DISORDER 14 0.0002
797 ARTHROPATHY 11 0.0002
798 HEADACHE 123 0.0002
799 EYE PAIN 11 0.0002
800 PERIPHERAL SWELLING 30 0.0002
801 DISEASE PROGRESSION 23 0.0002
802 ASTHENIA 73 0.0002
803 EJECTION FRACTION DECREASED 3 0.0002
804 C-REACTIVE PROTEIN INCREASED 7 0.0002
805 URTICARIA 32 0.0002
806 PULMONARY EMBOLISM 18 0.0002
807 RETCHING 4 0.0002
808 CONFUSIONAL STATE 30 0.0002
809 THROAT TIGHTNESS 5 0.0002
810 SKIN LESION 5 0.0002
811 INFUSION RELATED REACTION 12 0.0002
812 GASTROINTESTINAL HAEMORRHAGE 15 0.0002
813 INFLUENZA 20 0.0002
814 GLOSSODYNIA 4 0.0002
815 COUGH 50 0.0002
816 HEART RATE IRREGULAR 4 0.0002
817 ASTHMA 20 0.0002
818 INTERNATIONAL NORMALISED RATIO INCREASED 5 0.0002
819 CARDIAC FAILURE CONGESTIVE 14 0.0002
820 CONSTIPATION 38 0.0002
821 TINNITUS 8 0.0002
822 MUSCLE TWITCHING 4 0.0002
823 UPPER RESPIRATORY TRACT INFECTION 8 0.0002
824 GENERAL PHYSICAL HEALTH DETERIORATION 20 0.0002
825 PAIN 106 0.0002
826 HAEMORRHAGE 18 0.0002
827 BLINDNESS 7 0.0002
828 HYPOXIA 6 0.0002
829 ACUTE MYOCARDIAL INFARCTION 5 0.0002
830 DEEP VEIN THROMBOSIS 11 0.0002
831 WHEEZING 10 0.0002
832 BLOOD POTASSIUM DECREASED 5 0.0002
833 LACRIMATION INCREASED 5 0.0002
834 PARAESTHESIA 26 0.0002
835 AGITATION 12 0.0002
836 RECTAL HAEMORRHAGE 7 0.0002
837 CHILLS 19 0.0002
838 MEDICATION ERROR 9 0.0002
839 ABASIA 4 0.0002
840 CONJUNCTIVITIS 3 0.0002
841 BACTERIAL INFECTION 3 0.0002
842 HAEMATEMESIS 4 0.0002
843 HIP FRACTURE 5 0.0002
844 ABDOMINAL PAIN UPPER 32 0.0002
845 DYSPHONIA 9 0.0002
846 MUCOSAL INFLAMMATION 4 0.0002
847 STAPHYLOCOCCAL INFECTION 5 0.0002
848 ABDOMINAL PAIN 35 0.0002
849 NAUSEA 119 0.0002
850 BLOOD CHOLESTEROL INCREASED 7 0.0002
851 IRRITABILITY 9 0.0001
852 GASTROOESOPHAGEAL REFLUX DISEASE 12 0.0001
853 BLOOD GLUCOSE INCREASED 28 0.0001
854 PSORIATIC ARTHROPATHY 6 0.0001
855 BONE MARROW FAILURE 3 0.0001
856 HYPERHIDROSIS 19 0.0001
857 PRURITUS 56 0.0001
858 DIZZINESS 72 0.0001
859 DIARRHOEA 93 0.0001
860 RHABDOMYOLYSIS 6 0.0001
861 FATIGUE 112 0.0001
862 SEPSIS 16 0.0001
863 ROAD TRAFFIC ACCIDENT 6 0.0001
864 HAEMOPTYSIS 4 0.0001
865 DERMATITIS 3 0.0001
866 WOUND 4 0.0001
867 BURNING SENSATION 10 0.0001
868 BLISTER 8 0.0001
869 CONVULSION 8 0.0001
870 CRYING 5 0.0001
871 MYOCARDIAL INFARCTION 24 0.0001
872 RESTLESSNESS 5 0.0001
873 TREATMENT FAILURE 11 0.0001
874 LOSS OF CONSCIOUSNESS 17 0.0001
875 PANCREATITIS 7 0.0001
876 DEPRESSED MOOD 7 0.0001
877 VISION BLURRED 18 0.0001
878 EPILEPSY 4 0.0001
879 WHITE BLOOD CELL COUNT INCREASED 5 0.0001
880 MALAISE 57 0.0001
881 DISTURBANCE IN ATTENTION 7 0.0001
882 CARDIAC DISORDER 12 0.0001
883 BALANCE DISORDER 11 0.0001
884 TREMOR 21 0.0001
885 DEPRESSED LEVEL OF CONSCIOUSNESS 5 0.0001
886 OVERDOSE 27 0.0001
887 INTENTIONAL OVERDOSE 8 0.0001
888 TOXICITY TO VARIOUS AGENTS 21 0.0001
889 EMOTIONAL DISTRESS 15 0.0001
890 LACTIC ACIDOSIS 4 0.0001
891 FLATULENCE 7 0.0001
892 IMPAIRED HEALING 4 0.0001
893 BRONCHITIS 9 0.0001
894 DYSGEUSIA 9 0.0001
895 PRODUCT USE IN UNAPPROVED INDICATION 30 0.0001
896 PNEUMONIA 39 0.0001
897 AGEUSIA 3 0.0001
898 SKIN DISORDER 4 0.0001
899 POLLAKIURIA 5 0.0001
900 TRANSIENT ISCHAEMIC ATTACK 4 0.0001
901 FALL 39 0.0001
902 PRODUCT USE ISSUE 22 0.0001
903 DECREASED APPETITE 27 0.0001
904 VERTIGO 7 0.0001
905 RASH MACULAR 4 0.0001
906 ANHEDONIA 3 0.0001
907 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 8 0.0001
908 BACK PAIN 26 0.0001
909 DYSPEPSIA 11 0.0001
910 INFLUENZA LIKE ILLNESS 9 0.0001
911 RHINORRHOEA 7 0.0001
912 AMNESIA 7 0.0001
913 DEMENTIA 3 0.0001
914 ACCIDENTAL EXPOSURE TO PRODUCT 11 0.0001
915 DYSPNOEA EXERTIONAL 4 0.0001
916 HOT FLUSH 8 0.0001
917 COVID-19 18 0.0001
918 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 3 0.0001
919 MEMORY IMPAIRMENT 14 0.0001
920 CATARACT 6 0.0001
921 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 7 0.0001
922 DISCOMFORT 6 0.0001
923 MOBILITY DECREASED 7 0.0001
924 OSTEOPOROSIS 4 0.0001
925 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 5 0.0001
926 FEELING ABNORMAL 22 0.0001
927 HAEMATOCHEZIA 5 0.0001
928 INJECTION SITE PRURITUS 6 0.0001
929 RASH 39 0.0001
930 LOWER RESPIRATORY TRACT INFECTION 4 0.0001
931 MALIGNANT NEOPLASM PROGRESSION 9 0.0001
932 DELIRIUM 3 0.0001
933 HYPERSENSITIVITY 16 0.0001
934 BONE PAIN 5 0.0001
935 SURGERY 5 0.0001
936 RENAL CANCER 4 0.0001
937 MIGRAINE 8 0.0001
938 PRODUCTIVE COUGH 4 0.0001
939 ELECTROCARDIOGRAM QT PROLONGED 3 0.0001
940 DRUG INTOLERANCE 8 0.0001
941 NO ADVERSE EVENT 15 0.0001
942 LUNG DISORDER 4 0.0001
943 INJECTION SITE PAIN 25 0.0001
944 DRUG WITHDRAWAL SYNDROME 7 0.0001
945 SUICIDAL IDEATION 7 0.0001
946 ECZEMA 4 0.0001
947 ABNORMAL BEHAVIOUR 3 0.0001
948 INJECTION SITE BRUISING 6 0.0001
949 RASH PRURITIC 4 0.0001
950 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 4 0.0001
951 PANCYTOPENIA 4 0.0001
952 ABDOMINAL DISCOMFORT 12 0.0001
953 SEIZURE 8 0.0001
954 DEVICE DISLOCATION 3 0.0001
955 INTENTIONAL PRODUCT USE ISSUE 6 0.0001
956 ALOPECIA 13 0.0001
957 STOMATITIS 4 0.0001
958 INCORRECT DOSE ADMINISTERED 15 0.0001
959 FEELING HOT 4 0.0001
960 ADVERSE EVENT 6 0.0001
961 OROPHARYNGEAL PAIN 6 0.0001
962 INJECTION SITE ERYTHEMA 8 0.0001
963 PRODUCT DOSE OMISSION 4 0.0001
964 PSORIASIS 8 0.0001
965 FEBRILE NEUTROPENIA 4 0.0001
966 NEOPLASM MALIGNANT 4 0.0001
967 FLUSHING 6 0.0001
968 GASTROINTESTINAL DISORDER 5 0.0001
969 UNEVALUABLE EVENT 4 0.0001
970 ACNE 4 0.0001
971 INJECTION SITE HAEMORRHAGE 4 0.0001
972 SKIN EXFOLIATION 4 0.0000
973 DEVICE EXPULSION 3 0.0000
974 WHITE BLOOD CELL COUNT DECREASED 5 0.0000
975 INTENTIONAL PRODUCT MISUSE 4 0.0000
976 DEVICE DIFFICULT TO USE 3 0.0000
977 DRY SKIN 6 0.0000
978 DEVICE ISSUE 4 0.0000
979 BREAST CANCER 4 0.0000
980 DRUG DOSE OMISSION 7 0.0000
981 NEUROPATHY PERIPHERAL 4 0.0000
982 DEATH 34 0.0000
983 HOSPITALISATION 6 0.0000
984 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 7 0.0000
985 ILLNESS 4 0.0000
986 ADVERSE DRUG REACTION 3 0.0000
987 DRUG DEPENDENCE 5 0.0000
988 PRODUCT QUALITY ISSUE 4 0.0000
989 PRODUCT DOSE OMISSION ISSUE 8 0.0000